AI Summary & Key Takeaways
AI InsightIn this article, we aimed to present a difficult case of genitourinary tuberculosis (TB) who received quadruple antituberculosis treatment and whose liver enzyme elevation was attributed to COVID-19 infection, not drug side effect, and whose liver function tests completely recovered after COVID-19 treatment.
📌 3 Key Takeaways
Abstract
The coronavirus disease 2019 (COVID-19) continues to affect our country as well as all over the world. Although the most common symptoms are fever, dry cough, and fatigue, it is seen that there are very different presentations of the disease as the number of infected patients increases. In this article, we aimed to present a difficult case of genitourinary tuberculosis (TB) who received quadruple antituberculosis treatment and whose liver enzyme elevation was attributed to COVID-19 infection, not drug side effect, and whose liver function tests completely recovered after COVID-19 treatment.
Özet
Koronavirüs hastalığı 2019 (COVID-19) tüm dünyada olduğu gibi ülkemizde de etkisini sürdürmektedir. En sık semptomları; ateş yüksekliği, kuru öksürük, yorgunluk gibi semptomlar olsa da enfekte hasta sayısı arttıkça hastalığın çok farklı sunumlarının da olduğu görülmektedir. Biz yazıda, genitoüriner tüberküloz (TB) nedeni ile 4’lü antitüberkuloz tedavisi alan, karaciğer enzim yüksekliği ilaç yan etkisine değil de COVID-19 enfeksiyonuna bağlanan ve COVID-19 tedavisi sonrası karaciğer fonksiyon testleri tamamen düzelen zor bir olguyu sunmayı amaçladık.